Oncology Specialist at BillionToOne

Dallas, Texas, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, DiagnosticsIndustries

Requirements

Bachelor's Degree or equivalent experience
Experience selling diagnostic testing in the oncology field and maintaining a strong network of relationships with oncologists; demonstrated successful sales track record (e.g., award winner - President Club, Chairman Club, Rookie of the Year or equivalent) or experience as a Physicians Assistant (PA), Nurse Practitioner (NP) or Registered Nurse (RN) ordering late stage cancer liquid biopsy tests
Understanding of buyer/decision maker types, listening, presentation skills, and ability to assess and respond to customer needs
Lives within the defined territory and centrally located to defined accounts
Commitment to travel within defined territory
Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and ext

Responsibilities

Increasing revenue and driving market development through direct sales to individual Oncologists
Creating and implementing a strategic business plan to grow revenue quickly in your geography
Sales efforts include effective prospecting and cultivating new business and maintaining key relationships

Skills

Key technologies and capabilities for this role

OncologyMolecular DiagnosticsLiquid BiopsyCell-free DNAcfDNAQCT Technology

Questions & Answers

Common questions about this position

What is the salary for the Oncology Specialist position?

This information is not specified in the job description.

Is the Oncology Specialist role remote or office-based?

This is a remote, field-based position in Dallas that reports to a Regional Manager - Oncology.

What skills or expertise are required for the Oncology Specialist role?

The role requires scientific and clinical expertise in oncology, with responsibilities including driving sales to oncologists and cultivating relationships in the cancer care community.

What is the company culture like at BillionToOne?

BillionToOne maintains a unique culture that is diverse, passionate, and innovative despite significant growth, and has been recognized by Forbes as one of America's Best Startup Employers for 2024.

What makes a strong candidate for the Oncology Specialist position?

A strong candidate is a field-based professional with scientific and clinical expertise in oncology, capable of driving sales, growing revenue, and building relationships with oncologists in the Dallas area.

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free